However, in a Mendelian randomization experiment, we associated a decorin eQTL in human fibroblasts with increased risk of diabetic nephropathy, suggesting that species‐ and cell‐type‐specific effects should be considered when therapeutically targeting decorin. The gene discussed is DCN; the disease is diabetic kidney disease.